Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Pfister

Showing results (121-130 of 194) with videos related to

Pageof 20
Sort By:
Urologia Internationalis|August 14, 2020
Prediction of Radioresistant Prostate Cancer Based on Differentially Expressed ProteinsTim Nestler, Maike Wittersheim, Stephan Schaefer, et al.
Translational Andrology and Urology|May 10, 2021
The combination of microRNA-371a-3p and 375-5p can distinguish viable germ cell tumor and teratoma from necrosis in postchemotherapy retroperitoneal lymph node dissection specimensLara Kremer, Melanie von Brandenstein, Maike Wittersheim, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 2025
Cost-effectiveness analysis of perioperative durvalumab plus platin-based chemotherapy in muscle invasive bladder cancer in GermanyConstantin Rieger, Jörg Schlüchtermann, Julian Heidenreich, et al.
European Urology|November 15, 2011
Residual tumor size and IGCCCG risk classification predict additional vascular procedures in patients with germ cell tumors and residual tumor resection: a multicenter analysis of the German Testicular Cancer Study GroupChristian Winter, David Pfister, Jonas Busch, et al.
Journal of Palliative Medicine|May 25, 2013
German nursing home professionals' knowledge and specific self-efficacy related to palliative careDavid Pfister, Sebastian Markett, Monika Müller, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2019
Engaging Community-Based Cancer Physicians: Experience of the Memorial Sloan Kettering Cancer Center Cancer AllianceAllison Lipitz-Snyderman, Jessica Kennington, Brooke Hogan, et al.
World Journal of Urology|April 4, 2023
German specialists treating testicular cancer follow different guidelines with resulting inconsistency in assessment of retroperitoneal lymph-node metastasis: clinical implications and possible corrective measuresJustine Schoch, Kathrin Haunschild, Angelina Strauch, et al.
Urologia Internationalis|June 15, 2021
Teratomatous Elements in Orchiectomy Specimens Are Associated with a Reduced Relapse-Free Survival in Metastasized Testicular Germ Cell TumorsPia Paffenholz, Tim Nestler, Yasmine Maatoug, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 14, 2015
Extent of disease in recurrent prostate cancer determined by [(68)Ga]PSMA-HBED-CC PET/CT in relation to PSA levels, PSA doubling time and Gleason scoreFrederik A Verburg, David Pfister, Axel Heidenreich, et al.
World Journal of Urology|July 29, 2022
Prognostic factors in patients with clinical stage I nonseminoma-beyond lymphovascular invasion: a systematic reviewFriedemann Zengerling, Dirk Beyersdorff, Jonas Busch, et al.
Pageof 20

Showing results (121-130 of 194) with videos related to

Sort By:
Pageof 20
Urologia Internationalis|August 14, 2020
Prediction of Radioresistant Prostate Cancer Based on Differentially Expressed ProteinsTim Nestler, Maike Wittersheim, Stephan Schaefer, et al.
Translational Andrology and Urology|May 10, 2021
The combination of microRNA-371a-3p and 375-5p can distinguish viable germ cell tumor and teratoma from necrosis in postchemotherapy retroperitoneal lymph node dissection specimensLara Kremer, Melanie von Brandenstein, Maike Wittersheim, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 2025
Cost-effectiveness analysis of perioperative durvalumab plus platin-based chemotherapy in muscle invasive bladder cancer in GermanyConstantin Rieger, Jörg Schlüchtermann, Julian Heidenreich, et al.
European Urology|November 15, 2011
Residual tumor size and IGCCCG risk classification predict additional vascular procedures in patients with germ cell tumors and residual tumor resection: a multicenter analysis of the German Testicular Cancer Study GroupChristian Winter, David Pfister, Jonas Busch, et al.
Journal of Palliative Medicine|May 25, 2013
German nursing home professionals' knowledge and specific self-efficacy related to palliative careDavid Pfister, Sebastian Markett, Monika Müller, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2019
Engaging Community-Based Cancer Physicians: Experience of the Memorial Sloan Kettering Cancer Center Cancer AllianceAllison Lipitz-Snyderman, Jessica Kennington, Brooke Hogan, et al.
World Journal of Urology|April 4, 2023
German specialists treating testicular cancer follow different guidelines with resulting inconsistency in assessment of retroperitoneal lymph-node metastasis: clinical implications and possible corrective measuresJustine Schoch, Kathrin Haunschild, Angelina Strauch, et al.
Urologia Internationalis|June 15, 2021
Teratomatous Elements in Orchiectomy Specimens Are Associated with a Reduced Relapse-Free Survival in Metastasized Testicular Germ Cell TumorsPia Paffenholz, Tim Nestler, Yasmine Maatoug, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 14, 2015
Extent of disease in recurrent prostate cancer determined by [(68)Ga]PSMA-HBED-CC PET/CT in relation to PSA levels, PSA doubling time and Gleason scoreFrederik A Verburg, David Pfister, Axel Heidenreich, et al.
World Journal of Urology|July 29, 2022
Prognostic factors in patients with clinical stage I nonseminoma-beyond lymphovascular invasion: a systematic reviewFriedemann Zengerling, Dirk Beyersdorff, Jonas Busch, et al.
Pageof 20